In AD patients, reduced miR-22 levels in AD patients are associated with increased NLRP3 activation, while overexpression of miR-22 inhibits GSDMD-mediated pyroptosis, thereby reducing neuroinflammation and cognitive decline in AD mice (107). Here, GSDMD is linked to Alzheimer disease.